BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 27, 2025
See today's BioWorld
Home
» Final closing takes Rigontec's series A financing to $33M
To read the full story,
subscribe
or
sign in
.
Final closing takes Rigontec's series A financing to $33M
Sep. 7, 2016
By
Cormac Sheridan
DUBLIN – A syndicate of European venture capital investors has followed its own money in a sizable third closing of Rigontec GmbH's series A round, adding €15 million (US$16.7 million) in new cash, which takes the final tally to €29.25 million.
BioWorld